Unveiling Refarmed Chemical's Mastery in Advanced Pharmaceutical Innovations
In the realm of pharmaceuticals, Refarmed Chemical has established itself as a key player, boasting an impressive portfolio of Active Pharmaceutical Ingredients (APIs). The company's top APIs are especially significant, contributing to an estimated 40% of its total revenues in 2020. These APIs, each with unique properties and applications, have marked their territory in the pharmaceutical industry, with Refarmed Chemical leading the charge.
Here are some top APIs from Refarmed Chemical that are distributed by strategic partner DKSH Performance Materials Business Unit:
Indapamide, a thiazide diuretic, primarily used to treat hypertension and edema resulting from congestive heart failure, it has carved out a niche for itself in the cardiovascular health segment.
Mesalazine is an anti-inflammatory aminosalicylate medication. It plays a crucial role in treating and maintaining remission of mild to moderately active ulcerative colitis. Despite the market being dominated by originator formulations like Pentasa and Asacol, Refarmed has achieved a significant breakthrough by coordinating between a Chinese manufacturer and a leading Japanese customer to launch an innovative "once-a-day" Finished Dosage Formulation (FDF).
Ketoconazole, a broad-spectrum antifungal API, is a cornerstone of Refarmed's portfolio. This versatile API is widely used to treat seborrheic dermatitis and fungal skin infections.
Trimebutine, a spasmolytic agent, is another standout API. It's primarily used for symptomatic treatment of irritable bowel syndrome (IBS) and managing postoperative paralytic ileus following abdominal surgery. Despite the market being historically controlled by European manufacturers, Refarmed has disrupted the status quo by introducing a high-quality, niche alternative product in China.
Levofloxacin, an antibiotic medication, is instrumental in treating a variety of bacterial infections, ranging from acute bacterial sinusitis and pneumonia to urinary tract infections and some types of gastroenteritis.
Bexarotene, on the other hand, is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T cell lymphoma (CTCL). As a third-generation retinoid, it has marked its presence strongly, with Refarmed being the market leader for Bexarotene API in the USA.
In conclusion, Refarmed Chemical's top APIs demonstrate the company's innovative approach and commitment to providing superior pharmaceutical solutions. The company's success lies not only in its diverse portfolio but also in its strategic business alliances or integration efforts and its sharp focus on high-potential niche markets. In the current economic downturn, strategic business alliances are even more important.
Refarmed's transition to become part of the DKSH Group represents one such strategic move, given that both entities are industry leaders in their respective fields. In these challenging times, such integrations undoubtedly serve as stable foundations, providing constant supply, competitive pricing for clients, and further API industry development.
Contact DKSH today to learn more about Refarmed’s top APIs and many other advanced APIs and solutions.
Authors Bio - Dr Loris Cereda
Role - Director Business Development, Switzerland
Contact - [email protected]